11/29
11:04 am
clgn
CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Medium
Report
CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
11/28
02:10 am
clgn
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]
Medium
Report
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]
11/27
08:56 am
clgn
CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
High
Report
CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
11/27
07:13 am
clgn
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]
Medium
Report
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]
11/27
07:00 am
clgn
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Medium
Report
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
11/26
07:11 am
clgn
What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings [Yahoo! Finance]
Low
Report
What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings [Yahoo! Finance]
11/12
07:00 am
clgn
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
High
Report
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
11/9
09:50 am
clgn
Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Invest In Growth [Yahoo! Finance]
Low
Report
Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Invest In Growth [Yahoo! Finance]